148 related articles for article (PubMed ID: 6548939)
41. Study on rectal administration of azithromycin by suppository for pediatric use.
Maeda M; Nakano Y; Aoyama T; Matsumoto Y; Fujito H
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):263-8. PubMed ID: 26833461
[TBL] [Abstract][Full Text] [Related]
42. Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration.
Breda M; Bianchi M; Ripamonti C; Zecca E; Ventafridda V; Panerai AE
Int J Clin Pharmacol Res; 1991; 11(2):93-7. PubMed ID: 1879993
[TBL] [Abstract][Full Text] [Related]
43. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
Kawashima S; Inoue Y; Shimeno T; Fujiwara H
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):498-505. PubMed ID: 2337965
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the bioavailability of oral, rectal and intramuscular promethazine.
Schwinghammer TL; Juhl RP; Dittert LW; Melethil SK; Kroboth FJ; Chung VS
Biopharm Drug Dispos; 1984; 5(2):185-94. PubMed ID: 6743785
[TBL] [Abstract][Full Text] [Related]
45. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
Ibraheem JJ; Paalzow L; Tfelt-Hansen P
Br J Clin Pharmacol; 1983 Dec; 16(6):695-9. PubMed ID: 6419759
[TBL] [Abstract][Full Text] [Related]
46. The systemic availability of meptazinol in man after oral and rectal doses.
Murray GR; Petitjean O; Franklin RA; Graham DF; Trouvin JH; Jacquot C
Eur J Clin Pharmacol; 1989; 36(3):279-82. PubMed ID: 2744068
[TBL] [Abstract][Full Text] [Related]
47. [Analgesic activity of morphine suppository in rats].
Kita A; Nakamura H; Kadokawa T; Tan T
Yakugaku Zasshi; 1990 May; 110(5):349-53. PubMed ID: 2376826
[TBL] [Abstract][Full Text] [Related]
48. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
[TBL] [Abstract][Full Text] [Related]
49. The morphine hydrogel suppository. A new sustained release rectal preparation.
Hanning CD; Vickers AP; Smith G; Graham NB; McNeil ME
Br J Anaesth; 1988 Aug; 61(2):221-7. PubMed ID: 3415895
[TBL] [Abstract][Full Text] [Related]
50. Absolute intramuscular, oral, and rectal bioavailability of alizapride.
Houin G; Barre J; Tillement JP
J Pharm Sci; 1984 Oct; 73(10):1450-3. PubMed ID: 6502497
[TBL] [Abstract][Full Text] [Related]
51. Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration.
Quiding H; Anderson P; Bondesson U; Boréus LO; Hynning PA
Eur J Clin Pharmacol; 1986; 30(6):673-7. PubMed ID: 3770062
[TBL] [Abstract][Full Text] [Related]
52. Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base.
Burstein AH; Fisher KM; McPherson ML; Roby CA
Pharmacotherapy; 2000 May; 20(5):562-7. PubMed ID: 10809343
[TBL] [Abstract][Full Text] [Related]
53. Interindividual variation in the ratio between plasma morphine and its metabolites in cancer patients.
Tateishi M; Ohashi K; Kobayashi K; Hashimoto T; Yamaguchi J; Fujioka H; Izawa K; Masada M
Int J Clin Pharmacol Res; 2003; 23(2-3):75-82. PubMed ID: 15018021
[TBL] [Abstract][Full Text] [Related]
54. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.
Appelbaum SJ; Mayersohn M; Dorr RT; Perrier D
Cancer Chemother Pharmacol; 1982; 8(1):93-8. PubMed ID: 7094203
[TBL] [Abstract][Full Text] [Related]
55. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
56. Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.
Savarese JJ; Goldenheim PD; Thomas GB; Kaiko RF
Clin Pharmacokinet; 1986; 11(6):505-10. PubMed ID: 3802690
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic characteristics of ketoprofen suppositories.
Caillé G; Besner JG; Lacasse Y; Vézina M
Biopharm Drug Dispos; 1980; 1(4):195-201. PubMed ID: 7448348
[TBL] [Abstract][Full Text] [Related]
58. Systemic availability of oral slow-release morphine in man.
Moore RA; McQuay HJ; Bullingham RE; Baldwin D; Allen MC
Ann Clin Biochem; 1985 May; 22 ( Pt 3)():226-31. PubMed ID: 4026183
[TBL] [Abstract][Full Text] [Related]
59. Naproxen plasma levels in volunteers after single-dose administration by oral and rectal routes.
Desager JP; Vanderbist M; Harvengt C
J Clin Pharmacol; 1976 Apr; 16(4):189-93. PubMed ID: 1262531
[TBL] [Abstract][Full Text] [Related]
60. The bioavailability of rectally administered morphine.
Jonsson T; Christensen CB; Jordening H; Frølund C
Pharmacol Toxicol; 1988 Apr; 62(4):203-5. PubMed ID: 3387374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
